Thomas Hanff to Male
This is a "connection" page, showing publications Thomas Hanff has written about Male.
Connection Strength
0.024
-
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes. J Heart Lung Transplant. 2021 09; 40(9):926-935.
Score: 0.003
-
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One. 2021; 16(4):e0248080.
Score: 0.003
-
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. Circ Heart Fail. 2021 Apr; 14(4):e007957.
Score: 0.003
-
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021 03; 9(3):275-284.
Score: 0.003
-
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure. Hypertension. 2020 11; 76(5):1526-1536.
Score: 0.003
-
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. J Clin Hypertens (Greenwich). 2020 10; 22(10):1780-1788.
Score: 0.003
-
Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure. Future Cardiol. 2021 01; 17(1):3-6.
Score: 0.003
-
Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients With Severe Heart Failure. Am J Cardiol. 2017 Dec 01; 120(11):2003-2007.
Score: 0.002